Malta vs Switzerland: Cause of death, by non-communicable diseases, female
Malta
84.5%
in 2021
Switzerland
83.5%
in 2021
Malta rank
19th
Switzerland rank
22nd
Cause of death, by non-communicable diseases, female over time
- Malta
- Switzerland
How they compare
Malta currently reports 84.5% against 83.5% in Switzerland, a difference of 1.0%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Switzerland ahead.
Malta ranks 19th and Switzerland ranks 22nd of 185 countries.
Across the 3 decades both report, Malta averaged higher in 1 and Switzerland in 2.
Head to head by decade
| Decade | Malta | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 89.2% | 89.7% | 0.5% | Switzerland |
| 2010s | 90.4% | 90.9% | 0.5% | Switzerland |
| 2020s | 85.0% | 81.7% | 3.3% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Malta or Switzerland?
- Malta, at 84.5% against 83.5% in Switzerland as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Malta and Switzerland?
- 1.0%, with Malta ahead.
- How many years of comparable data are there for Malta and Switzerland?
- 6 years are reported by both, from 2000 to 2021.
- How do Malta and Switzerland rank globally for cause of death, by non-communicable diseases, female?
- Malta ranks 19th and Switzerland ranks 22nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.